Latest stories on ALKS
Alkermes: A Slow-Burning Buy Prospect On Orexin-Agonist Promise
Seeking Alpha63 · neutralanalyst
Alkermes Announces Launch of 9th Annual Alkermes Pathways Research Awards® Program
StockTitan55 · neutralgeneral
Tortugas Neuroscience Announces Appointment of Jim Frates to Board of Directors
StockTitan55 · neutralgeneral
Mizuho survey shows no consensus into Alkermes ADHD data
The Fly47 · neutralgeneral
Alkeus Announces Publication in JAMA Ophthalmology of Efficacy and Safety Results from the TEASE-1 Study of Gildeuretinol in Stargardt Disease
Business Insider67 · bullishproduct/pr
Mizuho reiterates Alkermes stock rating ahead of ADHD trial data
Investing.com Analyst Ratings56 · neutralanalyst
Alkermes Chief Commercial Officer Sells 7,576 Shares for $373,000
Yahoo Finance52 · neutralgeneral
Alkermes Chief Commercial Officer Sells 7,576 Shares for $373,000
The Motley Fool48 · neutralgeneral
Alkermes’ alixorexton featured in published Phase 2 study of narcolepsy
The Fly59 · neutralproduct/pr
Alkermes Amends Credit Agreement to Lower Borrowing Costs
TipRanks56 · neutralgeneral
Alkermes plc. (ALKS) files 8-K
SEC 8-K50 · neutralgeneral
Could Alkermes plc (ALKS) Stock Rebound After Investors Look Beyond Near-Term Profit Pressure?
Yahoo Top54 · neutralgeneral
8-K/A - Alkermes plc. (ALKS) files 8-K
SEC 8-K50 · neutralgeneral
Alkermes plc 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
H.C. Wainwright reiterates Neutral stock rating on Alkermes
Investing.com Analyst Ratings50 · neutralanalyst
Alkermes plc Q2 2026 Earnings Call Summary
Yahoo Finance50 · neutralearnings
Alkermes expects Q3 2026 total revenues of $450M-$470M as CEO transition and orexin readouts approach
Seeking Alpha58 · neutralearnings
Alkermes plc (ALKS) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Piper Sandler raises Alkermes stock price target on pipeline value
Investing.com Analyst Ratings61 · neutralanalyst
Alkermes GAAP EPS of $0.00, revenue of $496M
Seeking Alpha50 · neutralearnings
Alkermes plc. (ALKS) files 8-K
SEC 8-K50 · neutralgeneral
Alkermes plc Reports Second Quarter 2026 Financial Results
StockTitan50 · neutralearnings
Alkermes Q2 2026 Earnings Preview
Seeking Alpha55 · neutralearnings
Stifel raises Alkermes stock price target on orexin program outlook
Investing.com Analyst Ratings61 · neutralanalyst